
Trump Expected to Nominate White House Adviser for FDA Commissioner
President Trump is expected to nominate Heidi Overton, a White House adviser, to lead the Food and Drug Administration.

President Trump is expected to nominate Heidi Overton, a White House adviser, to lead the Food and Drug Administration.

Bon Secours Mercy Health, a nonprofit health system, has earned significant revenue from its minority position in Ensemble Health Partners, a medical billing firm.

Compensation for health care CEOs in Massachusetts has increased, despite challenges faced by hospital systems.

States face a September 30 deadline to decide whether to participate in a federal program offering 'most-favored nation' drug prices for Medicaid. The program aims to reduce costs, but its long-term impact remains uncertain.

Epic Systems, the nation's dominant seller of electronic health records software, is facing a series of unprecedented challenges driven by antitrust lawsuits, questions about its artificial intelligence strategy, and an exodus of key technology leaders.

AstraZeneca discontinues a late-stage trial for its experimental drug volrustomig, while prescription drug prices in the U.S. experience a significant decline.

Health Secretary Robert F. Kennedy Jr. recently visited California to discuss changes to addiction treatment, placing blame on the prior administration for handling the issue.

Valisure accuses USP of making false and misleading remarks about its testing methods, sparking a lawsuit.